JOHANNA GRAY

ARTEMIS POLICY GROUP LLC · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

last 3 years

Filings

18 agencies contacted

Activity

filings by quarter

Works on

Medicare/Medicaid 14 Budget/Appropriations 12 Insurance 11 Health Issues 8 Pharmacy 7 Medical/Disease Research/Clinical Labs 6

Background

Government experience

Intern

Senator Barack Obama

Disclosed on LD-2 filings

Senator Barack Obama

Intern

Disclosed on LD-2 filings

Career

ARTEMIS POLICY GROUP LLC

Washington, DC

2024 - present

Specific issues

Blood and plasma safety and awareness Bleeding disorders awareness Securing Equal Access to Research, Care, and Health (SEARCH) Act Creating Hope Reauthorization Act of 2024 (HR 7384) Prohibition on Creditors and Consumer Reporting Agencies Concerning Medical Information (Regulation V) (CFPB-2024- 0023)

Health Issues · 2024 Q3

FY25 House and Senate Labor-HHS Appropriations bills

Budget/Appropriations · 2024 Q3

Hemophilia research, prevention, surveillance and service programs and issues H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Letter in response to Congressional Framework on Reforming the National Institutes of Health Letter in response to FDA Draft Guidance on Diversity Action Plans

Medical/Disease Research/Clinical Labs · 2024 Q3

Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Issues related to 1332 state innovation waivers H.J. Res. 181, Congressional Review Act resolution to stop the Biden-Harris rule limiting access to Association Health Plans (AHPs) Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) AIMED Alliance Citizens Petition re drug importation and alternative payment models

Insurance · 2024 Q3

Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program

Pharmacy · 2024 Q3

Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid Comments in response to CY 2025 Medicare Physician Fee Schedule Comments in response to CY 2025 Medicare HOPPS proposed rule

Medicare/Medicaid · 2024 Q3